Company profile for Rocket Pharmaceuticals

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Best-in-class curative gene & cell therapies for patients with devastating diseases. Rocket’s pipeline is comprised of first-in-class gene therapies for rare & devastating inherited diseases. Designed in collaboration with leading academic and industry partners, Rocket lentiviral-based programs aim to enable transduction of patients’ stem cells by means of 3rd-generation, self-inactivating lentiviral vectors to optimize th...
Best-in-class curative gene & cell therapies for patients with devastating diseases. Rocket’s pipeline is comprised of first-in-class gene therapies for rare & devastating inherited diseases. Designed in collaboration with leading academic and industry partners, Rocket lentiviral-based programs aim to enable transduction of patients’ stem cells by means of 3rd-generation, self-inactivating lentiviral vectors to optimize the potential for gene-correction & stem cell engraftment such that the functional deficits of each disorder are corrected, with sufficient quantities of healthy protein manufactured by patients’ own hematopoietic cells.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
The Empire State Building 350 Fifth Avenue Suite 7530 New York, NY 10118
Telephone
Telephone
646.440.9100
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

IPhEB Russia

Not Confirmed

envelop Contact Supplier

IPhEB Russia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.pharmiweb.com/press-release/2026-03-27/rocket-pharmaceuticals-announces-fda-approval-of-kresladi-for-pediatric-patients-with-severe-leukoc

PHARMIWEB
28 Mar 2026

https://www.pharmiweb.com/press-release/2026-02-23/rocket-pharmaceuticals-to-participate-in-upcoming-investor-conferences

PHARMIWEB
23 Feb 2026

https://www.biospace.com/business/jpm-day-3-rare-disease-in-the-spotlight

BIOSPACE
15 Jan 2026

https://www.businesswire.com/news/home/20260105175291/en/Rocket-Pharmaceuticals-to-Participate-in-the-44th-Annual-J.P.-Morgan-Healthcare-Conference

BUSINESSWIRE
05 Jan 2026

https://www.businesswire.com/news/home/20251125498119/en/Rocket-Pharmaceuticals-to-Participate-in-the-8th-Annual-Evercore-Healthcare-Conference

BUSINESSWIRE
25 Nov 2025

https://www.businesswire.com/news/home/20251106225105/en/Rocket-Pharmaceuticals-Reports-Third-Quarter-2025-Financial-Results-and-Highlights-Recent-Progress

BUSINESSWIRE
06 Nov 2025

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

Inspections and registrations

Upload your audits for free, ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty